International infant formula manufacturers are adjusting their business practices in China having been found guilty of price fixing. Multinational companies, which were the focus of an anti-trust investigation, say they have emerged from the probe with a "clearer understanding" of the regulatory framework in the country. However, some pundits suggest the probe must be viewed in the context of a wider government push to boost the domestic industry. Katy Askew reports.